EDTA chelation is a therapy by which repeated administrations of a weak synthetic amino acid (EDTA, ethylenediamine tetra-acetic acid) gradually reduce atherosclerotic plaque and other mineral deposits (in many patients) throughout the cardiovascular system by literally dissolving them away
EDTA removes toxic metals from the blood. Studies have shown that as people age they continuously accumulate toxic metals: lead, mercury, aluminum, iron, cadmium, and arsenic, among others. The accrual of these toxins invites an increased risk for various diseases, especially heart disease. The less of these metals we have in our bodies, the more likely we are to be physiologically healthy or simply feel good, and the lower our risk for heart disease. Because EDTA is so effective at removing unwanted metals and other minerals from the blood, it has been the standard, FDA-approved treatment for lead, mercury, aluminum, and cadmium poisoning for more than 50 years. EDTA normalizes the distribution of most metallic elements in the body
EDTA helps prevent heart attacks, stroke, varicose veins, and more by inhibiting blood clotting. Because EDTA inhibits blood clotting so well, by tying up calcium, it is routinely added to blood samples that are drawn for testing purposes. Blood can’t clot if the calcium is tied up. Inhibition of blood clotting can help prevent stroke, heart attack, phlebitis (painful inflammation of a vein), pulmonary embolism (potentially fatal clot to the lung), or varicose veins. Generally, these conditions are associated with aging.
I.V. chelation therapy has a direct and powerful effect on the body almost instantaneously. An I.V. session used to last about 3 to 4 hours, during which about 1500 mg to 3000 mg of EDTA (plus vitamin C and other nutrients) were administered. Now thanks to advancements in chelation therapies, a session usually lasts less than an hour. The number of treatments necessary (generally about 20-50 sessions) depends on the individual’s quantity of toxic heavy metals.
Candidates for I.V. chelation are people that have been diagnosed with heavy metal poisoning, fatigue, poor immune function, vertigo, symptoms of vascular occlusion or patients in need of revascularsation (such as those with diabetics and potential amputees).